Semglee® (insulin glargine) – New drug approval
June 11, 2020, - Mylan and Biocon announced the FDA approval of Semglee (insulin glargine), to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus (T1DM) and in adults with type 2 diabetes mellitus (T2DM).
Download PDF
